It bypasses first-pass hepatic metabolism which oral delivery does not allowing a greater proportion of the absorbed peptide to remain intact as it enters circulation.7 The olfactory pathway also provides a potential direct nose-to-brain route, bypassing the blood-brain barrier a property that has generated interest for neuropeptides and potential neurological applications
You should speak with us first if you: Are pregnant or breastfeeding Have certain medical conditions Are taking specific medications We will always ensure the treatment is appropriate for you
As we age, NAD+ levels decline significantly, contributing to fatigue, metabolic slowdowns, and cellular aging
Certain medical conditions, allergies, medications, pregnancy, breastfeeding, or recent illness may affect candidacy
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control